E Fund Management’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$188K Buy
+18,933
New +$169K 0.01% 453
2025
Q2
$70.1K Buy
20,258
+1,093
+6% +$3.25K ﹤0.01% 384
2025
Q1
$50.2K Buy
19,165
+1,511
+9% +$5.92K ﹤0.01% 393
2024
Q4
$72.7K Buy
17,654
+6,104
+53% +$33.2K ﹤0.01% 386
2024
Q3
$81.8K Sell
11,550
-228
-2% -$1.7K ﹤0.01% 345
2024
Q2
$76.8K Sell
11,778
-10,152
-46% -$69.4K ﹤0.01% 310
2024
Q1
$182K Buy
21,930
+4,444
+25% +$43.4K 0.01% 354
2023
Q4
$193K Sell
17,486
-1,917
-10% -$16.2K 0.01% 288
2023
Q3
$163K Sell
19,403
-14,305
-42% -$154K 0.01% 271
2023
Q2
$423K Buy
33,708
+8,516
+34% +$106K 0.03% 154
2023
Q1
$415K Buy
25,192
+512
+2% +$9.18K 0.03% 153
2022
Q4
$369K Buy
24,680
+11,197
+83% +$214K 0.03% 195
2022
Q3
$302K Sell
13,483
-6,992
-34% -$153K 0.03% 238
2022
Q2
$343K Buy
20,475
+12,110
+145% +$260K 0.03% 211
2022
Q1
$250K Buy
+8,365
New +$203K 0.01% 257

Other funds holding RLAY